117 related articles for article (PubMed ID: 21709542)
1. Amino acid substitutions in the hepatitis C virus core region are associated with postoperative recurrence and survival of patients with HCV genotype 1b-associated hepatocellular carcinoma.
Toyoda H; Kumada T; Kaneoka Y; Maeda A
Ann Surg; 2011 Aug; 254(2):326-32. PubMed ID: 21709542
[TBL] [Abstract][Full Text] [Related]
2. Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.
Ogura S; Akuta N; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Kobayashi M; Suzuki F; Suzuki Y; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
Intervirology; 2009; 52(4):179-88. PubMed ID: 19546575
[TBL] [Abstract][Full Text] [Related]
3. Impact of amino acid substitutions in the hepatitis C virus genotype 1b core region on liver steatosis and hepatic oxidative stress in patients with chronic hepatitis C.
Tachi Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Samejima Y; Goto H
Liver Int; 2010 Apr; 30(4):554-9. PubMed ID: 19951380
[TBL] [Abstract][Full Text] [Related]
4. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C.
Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y
J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
8. A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery.
Tsai HW; Lin YJ; Lin PW; Wu HC; Hsu KH; Yen CJ; Chan SH; Huang W; Su IJ
Cancer; 2011 Jul; 117(13):2951-60. PubMed ID: 21692054
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
Li HK; Qin Y; Li XM; Li Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
11. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma.
Eguchi S; Kanematsu T; Arii S; Omata M; Kudo M; Sakamoto M; Takayasu K; Makuuchi M; Matsuyama Y; Monden M;
Br J Surg; 2011 Apr; 98(4):552-7. PubMed ID: 21267990
[TBL] [Abstract][Full Text] [Related]
12. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
13. Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production.
Khaliq S; Jahan S; Pervaiz A
Infect Genet Evol; 2011 Apr; 11(3):543-56. PubMed ID: 21292033
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis C virus core shadow protein expressed in human hepatoma cell line on human gene expression profiles.
Dou J; Liu P; Wang J; Zhang X
J Gastroenterol Hepatol; 2006 Dec; 21(12):1794-800. PubMed ID: 17074016
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
19. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
